Literature DB >> 17047217

Incidence, causes, and outcomes of dilated cardiomyopathy in children.

Jeffrey A Towbin1, April M Lowe, Steven D Colan, Lynn A Sleeper, E John Orav, Sarah Clunie, Jane Messere, Gerald F Cox, Paul R Lurie, Daphne Hsu, Charles Canter, James D Wilkinson, Steven E Lipshultz.   

Abstract

CONTEXT: Dilated cardiomyopathy (DCM) is the most common form of cardiomyopathy and cause of cardiac transplantation in children. However, the epidemiology and clinical course of DCM in children are not well established.
OBJECTIVE: To provide a detailed description of the incidence, causes, outcomes, and related risk factors for DCM in children. DESIGN AND
SETTING: Longitudinal study based on a population-based, prospective cohort of children diagnosed as having DCM since January 1, 1996, at 89 pediatric cardiac centers and a retrospectively collected cohort of patients seen primarily at large tertiary care centers in North America and who had diagnoses between January 1, 1990, and December 31, 1995, and were enrolled through February 2003. PARTICIPANTS: A total of 1426 children from the United States and Canada diagnosed as having DCM at younger than 18 years. Primary DCM was determined by strict echocardiographic and/or pathologic criteria. Patients with disease due to endocrine, immunologic, drug toxicity, and other causes were excluded. MAIN OUTCOME MEASURES: Annual incidence per 100,000 children; mortality; cardiac transplantation.
RESULTS: The annual incidence of DCM in children younger than 18 years was 0.57 cases per 100,000 per year overall. The annual incidence was higher in boys than in girls (0.66 vs 0.47 cases per 100,000; P<.001), in blacks than in whites (0.98 vs 0.46 cases per 100,000; P<.001), and in infants (<1 year) than in children (4.40 vs 0.34 cases per 100,000; P<.001). The majority of children (66%) had idiopathic disease. The most common known causes were myocarditis (46%) and neuromuscular disease (26%). The 1- and 5-year rates of death or transplantation were 31% and 46%, respectively. Independent risk factors at DCM diagnosis for subsequent death or transplantation were older age, congestive heart failure, lower left ventricular fractional shortening Z score, and cause of DCM (P<.001 for all).
CONCLUSIONS: In children, DCM is a diverse disorder with outcomes that depend largely on cause, age, and heart failure status at presentation. Race, sex, and age affect the incidence of disease. Most children do not have a known cause of DCM, which limits the potential for disease-specific therapies.

Entities:  

Mesh:

Year:  2006        PMID: 17047217     DOI: 10.1001/jama.296.15.1867

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  273 in total

1.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

2.  Cardiomyopathies: Treating pediatric DCM--great expectations unfulfilled.

Authors:  Charles E Canter
Journal:  Nat Rev Cardiol       Date:  2010-08       Impact factor: 32.419

3.  Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy.

Authors:  Neal K Lakdawala; Lisa Dellefave; Charles S Redwood; Elizabeth Sparks; Allison L Cirino; Steve Depalma; Steven D Colan; Birgit Funke; Rebekah S Zimmerman; Paul Robinson; Hugh Watkins; Christine E Seidman; J G Seidman; Elizabeth M McNally; Carolyn Y Ho
Journal:  J Am Coll Cardiol       Date:  2010-01-26       Impact factor: 24.094

4.  Multiple old myocardial scars and new onset of myocarditis in two young patients presenting with ventricular tachycardias and dilated cardiomyopathy.

Authors:  Anamaria Wolf-Puetz; Matthias Wein; Reinhard Niehues; Marc Horlitz; Malte Kelm; Karin Klingel; Reinhard Kandolf; Rolf Michael Klein
Journal:  Clin Res Cardiol       Date:  2010-12-03       Impact factor: 5.460

5.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

Review 6.  The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years.

Authors:  James D Wilkinson; David C Landy; Steven D Colan; Jeffrey A Towbin; Lynn A Sleeper; E John Orav; Gerald F Cox; Charles E Canter; Daphne T Hsu; Steven A Webber; Steven E Lipshultz
Journal:  Heart Fail Clin       Date:  2010-10       Impact factor: 3.179

7.  Pediatric and adult dilated cardiomyopathy represent distinct pathological entities.

Authors:  Meghna D Patel; Jayaram Mohan; Caralin Schneider; Geetika Bajpai; Enkhsaikhan Purevjav; Charles E Canter; Jeffrey Towbin; Andrea Bredemeyer; Kory J Lavine
Journal:  JCI Insight       Date:  2017-07-20

8.  Pediatric dilated cardiomyopathy hearts display a unique gene expression profile.

Authors:  Philip D Tatman; Kathleen C Woulfe; Anis Karimpour-Fard; Danielle A Jeffrey; James Jaggers; Joseph C Cleveland; Karin Nunley; Matthew Rg Taylor; Shelley D Miyamoto; Brian L Stauffer; Carmen C Sucharov
Journal:  JCI Insight       Date:  2017-07-20

9.  Rbm20-deficient cardiogenesis reveals early disruption of RNA processing and sarcomere remodeling establishing a developmental etiology for dilated cardiomyopathy.

Authors:  Rosanna Beraldi; Xing Li; Almudena Martinez Fernandez; Santiago Reyes; Frank Secreto; Andre Terzic; Timothy M Olson; Timothy J Nelson
Journal:  Hum Mol Genet       Date:  2014-02-28       Impact factor: 6.150

10.  Toward Personalized Medicine: Does Genetic Diagnosis of Pediatric Cardiomyopathy Influence Patient Management?

Authors:  Teresa M Lee; Stephanie M Ware
Journal:  Prog Pediatr Cardiol       Date:  2015-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.